Compare Mutual Funds
Pros | 5Y returns in the top 25% of the category. 3Y returns in the top 25% of the category. Lower expense ratio. | Larger AUM within category. Beats FD returns for both 3Y & 5Y duration. | ||
Cons | - | 3Y returns in the bottom 25% of the category. |
INDMoney rank | 3/8 | 6/8 | ||
Category | Equity, Sector - Healthcare | Equity, Sector - Healthcare | ||
Fund Age | 7 Years 10 Months | 13 Years 4 Months | ||
Fund AUM | ₹2844 Cr | ₹8306 Cr | ||
Min Investment |
|
| ||
Expense Ratio | 0.47% | 0.93% | ||
Exit Load | 1% | 1% | ||
Benchmark Index | BSE Healthcare TR INR | BSE Healthcare TR INR |
No of Holdings | 35 | 39 | ||
Top 5 Holdings |
|
| ||
No of Sectors | 2 | 1 | ||
Top 3 Sectors |
| Health (100%) | ||
Equity % | 99.72% | 99.7% | ||
Debt % | - | - | ||
P/E | 39.46 | 35.73 | ||
P/B | 5.5 | 5.7 | ||
Credit Quality | - | - | ||
Modified Duration | - | - | ||
YTM | - | - |
1-Month Return | -1.3% | -2.8% | ||
3-Month Return | -1.4% | -3.43% | ||
6-Month Return | -4.32% | -5.74% | ||
1-Year Return | 6.43% | 3.08% | ||
3-Year Return | 25.89% | 23.59% | ||
5-Year Return | 17.51% | 16.38% |
Sharpe | 1.17 | 1.17 | ||
Alpha | 0.09 | 0.22 | ||
Beta | 0.99 | 0.9 | ||
Standard Deviation | 16.44 | 15.21 | ||
Information Ratio | -0.06 | -0.47 |
Description | Mirae Asset Healthcare Fund is an equity fund.The fund could potentially beat inflation in the long-run. | Nippon India Pharma Fund is an equity fund.The fund could potentially beat inflation in the long-run. | ||
Managers | Tanmay Mehta, Vrijesh Kasera | Lokesh Maru, Sailesh Raj Bhan, Kinjal Desai, Divya Sharma |

